Exane Derivatives’s Bank of New York Mellon BNY Stock Holding History

Exane Derivatives’s Portfolio BNY Stock Details BNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	-$34	–	691
2020 Q1	$34	Sell	1 -244	-100%	-$10.2K	﹤0.01%	687
2019 Q4	$12.4K	Sell	245 -2,711	-92%	-$129K	﹤0.01%	410
2019 Q3	$134K	Hold	2,956	–	–	0.02%	290
2019 Q2	$130K	Buy	+2,956	New	+$139K	0.02%	297
2019 Q1	–	Sell	-212	Closed	-$9.98K	–	677
2018 Q4	$9.98K	Hold	212	–	–	﹤0.01%	463
2018 Q3	$10.9K	Buy	212 +2	+1%	+$105	﹤0.01%	440
2018 Q2	$11.5K	Sell	210 -4,422	-95%	-$244K	﹤0.01%	454
2018 Q1	$235K	Buy	4,632 +116	+3%	+$6.45K	0.05%	231
2017 Q4	$243K	Buy	4,516 +1,999	+79%	+$106K	0.04%	224
2017 Q3	$133K	Sell	2,517 -25	-1%	-$1.31K	0.02%	225
2017 Q2	$130K	Buy	+2,542	New	+$122K	0.03%	246

Other funds holding BNY

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Exane Derivatives's BNY Position: Q2 2020 in Review

Exane Derivatives sold out of Bank of New York Mellon (BNY) in Q2 2020, closing a stake of 1 share — an estimated $34 sold.

Exane Derivatives first reported a position in BNY in Q2 2017 and held it in 11 quarters. The position peaked at $243K in Q4 2017. 943 funds tracked by Wall St. Rank hold BNY as of Q2 2020.

Exane Derivatives reported no remaining Bank of New York Mellon position as of Q2 2020 after selling out during the quarter.
Exane Derivatives sold 1 Bank of New York Mellon share in Q2 2020, an estimated $34.
Exane Derivatives first reported a position in Bank of New York Mellon in Q2 2017 and held it in 11 quarters.
Exane Derivatives's Bank of New York Mellon position peaked at $243K in Q4 2017.
943 funds tracked by Wall St. Rank held Bank of New York Mellon as of Q2 2020.

Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.